(R)-N-((S)-1,3-Dihydrospiro[indene-2,4'-piperidin]-1-yl)-2-methylpropane-2-sulfinamide

Catalog No. :
ACPAZL791
CAS No. :
2245085-41-8
Molecular Formula :
C17H26N2OS
Molecular Weight :
306.48

IUPAC Name:(R)-N-((S)-1,3-dihydrospiro[indene-2,4'-piperidin]-1-yl)-2-methylpropane-2-sulfinamide

(R)-N-((S)-1,3-Dihydrospiro[indene-2,4'-piperidin]-1-yl)-2-methylpropane-2-sulfinamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$89.00Login to see priceInquiryInquiry
1g97%$266.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(R)-N-((S)-1,3-Dihydrospiro[indene-2,4'-piperidin]-1-yl)-2-methylpropane-2-sulfinamide
IUPAC Name(R)-N-((S)-1,3-dihydrospiro[indene-2,4'-piperidin]-1-yl)-2-methylpropane-2-sulfinamide
MDL No.-
Molecular FormulaC17H26N2OS
Molecular Weight306.48
SMILESCC([S@](N[C@H]1C2(CCNCC2)CC3=C1C=CC=C3)=O)(C)C
InChI KeyWJMSINQARSIDBW-QVKFZJNVSA-N
Synonym(R)-N-((S)-1,3-Dihydrospiro[indene-2,4'-piperidin]-1-yl)-2-methylpropane-2-sulfinamide | 2245085-41-8 | (R)-2-methyl-N-[(1S)-spiro[indane-2,4'-piperidine]-1-yl]propane-2-sulfinamide | SCHEMBL21855868 | BS-48183
CAS No.2245085-41-8
PubChem CID146485530

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACPAZL791 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACPAZL791 route product structure diagram
    ACPAZL7912245085-41-8
Inquiry

2. ACPAZL791 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACXRZK839 route compound structure diagram
    ACXRZK8392245085-40-7 In Stock
  2. Then
  3. ACPAZL791 route product structure diagram
    ACPAZL7912245085-41-8
Inquiry

Comments (0)